Eleventh-Hour Settlement in Cialis Patent Suit Clears Path for Generics
Generic drug makers, including Teva, had been set to go to trial Monday against Eli Lilly & Co. The deal ends Lilly's exclusivity over Cialis in 2018.
This premium content is reserved for National Law Journal subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now